Follow
DrCaty Ebel Bitoun
DrCaty Ebel Bitoun
HelpAging
Verified email at helpaging.com
Title
Cited by
Cited by
Year
The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis
CR Chapple, V Khullar, Z Gabriel, D Muston, CE Bitoun, D Weinstein
European urology 54 (3), 543-562, 2008
9502008
Efficacy and tolerability of mirabegron, a β3-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European–Australian phase 3 trial
V Khullar, G Amarenco, JC Angulo, J Cambronero, K Høye, I Milsom, ...
European urology 63 (2), 283-295, 2013
5742013
The impact of overactive bladder on mental health, work productivity and health‐related quality of life in the UK and Sweden: results from EpiLUTS
KS Coyne, CC Sexton, ZS Kopp, C Ebel‐Bitoun, I Milsom, C Chapple
BJU international 108 (9), 1459-1471, 2011
3072011
The relationship between BMI and urinary incontinence subgroups: results from EpiLUTS
V Khullar, CC Sexton, CL Thompson, I Milsom, CE Bitoun, KS Coyne
Neurourology and urodynamics 33 (4), 392-399, 2014
1242014
Flexible‐dose fesoterodine in elderly adults with overactive bladder: results of the randomized, double‐blind, placebo‐controlled study of fesoterodine in an aging population trial
A Wagg, V Khullar, D Marschall‐Kehrel, MC Michel, M Oelke, A Darekar, ...
Journal of the American Geriatrics Society 61 (2), 185-193, 2013
1192013
The impact of OAB on sexual health in men and women: results from EpiLUTS
KS Coyne, CC Sexton, C Thompson, ZS Kopp, I Milsom, SA Kaplan
The Journal of Sexual Medicine 8 (6), 1603-1615, 2011
1142011
Long‐term safety, tolerability and efficacy of flexible‐dose fesoterodine in elderly patients with overactive bladder: open‐label extension of the SOFIA trial
A Wagg, V Khullar, MC Michel, M Oelke, A Darekar, CE Bitoun
Neurourology and urodynamics 33 (1), 106-114, 2014
682014
Introduction of an infliximab biosimilar (CT-P13): a five-year budget impact analysis for the treatment of rheumatoid arthritis in Ireland
G McCarthy, CE Bitoun, H Guy
Value in Health 16 (7), A558, 2013
402013
Safety and efficacy of flexible-dose fesoterodine in British subjects with overactive bladder: insights into factors associated with dose escalation
L Cardozo, T Hall, J Ryan, C Ebel Bitoun, I Kausar, A Darekar, A Wagg
International urogynecology journal 23, 1581-1590, 2012
272012
Clinical value of a patient‐reported goal‐attainment measure: the global development of self‐assessment goal achievement (SAGA) questionnaire for patients with lower urinary …
V Khullar, M Espuna‐Pons, D Marschall‐Kehrel, A Fianu‐Jonasson, ...
Neurourology and urodynamics 33 (1), 90-94, 2014
162014
Effects of drug cessation after flexible‐dose fesoterodine in patients with overactive bladder
V Khullar, L Cardozo, CJ Kelleher, T Hall, J Ryan, C Ebel Bitoun, ...
BJU international 112 (6), 820-829, 2013
122013
880 ASSESSMENT OF FESOTERODINE TREATMENT IN OLDER PEOPLE WITH OVERACTIVE BLADDER: RESULTS OF SOFIA, A DOUBLE-BLIND, PLACEBO-CONTROLLED PAN EUROPEAN TRIAL
A Wagg, V Khullar, D Marschall-Kehrel, MC Michel, M Oelke, DG Tincello, ...
European Urology Supplements 2 (10), 276-277, 2011
92011
An observational study of patient satisfaction with fesoterodine in the treatment of overactive bladder: effects of additional educational material
T Schneider, D Arumi, TJ Crook, F Sun, MC Michel
International Journal of Clinical Practice 68 (9), 1074-1080, 2014
82014
Understanding Swedish patients’ expectations for treatment of their urinary symptoms
A Fianu-Jonasson, L Brubaker, C Kelleher, V Khullar, CE Bitoun, ...
Nordic Urogynecological Association, 2009
72009
The prevalence of OAB in the US, UK, and Sweden: results from EPILUTS
KS Coyne, CC Sexton, D Weinstein, ZS Kopp, C Ebel-Bitoun, I Milsom, ...
The Journal of Urology 181 (4S), 160-160, 2009
32009
The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis Editorial Comment
CR Chapple, V Khullar, Z Gabriel, D Muston, CE Bitoun, D Weinstein
JOURNAL OF UROLOGY 181 (6), 2649-2650, 2009
22009
687 Treatment with fesoterodine versus tolterodine for reducing symptom bother in elderly patients with overactive bladder including urgency urinary incontinence
T Schneider, A Bergqvist, J Wang, A Wagg, C Ebel-Bitoun
European Urology Supplements 1 (11), e687, e687a, 2012
12012
Efficacy and Tolerability of Fesoterodine in Older Subjects With Overactive Bladder: Results of SOFIA
AS Wagg, V Khullar, D Marschall-Kehrel, MC Michel, M Oelke, A Darekar, ...
Journal of the American Geriatrics Society 59, S124-S124, 2011
12011
O616 The impact of OAB on female sexual health: The EpiLUTS study
I Milsom, K Coyne, C Sexton, CE Bitoun, D Weinstein, Z Kopp
International Journal of Gynecology & Obstetrics 107, S268-S269, 2009
12009
58 THE PREVALENCE OF OAB IN SWEDEN, UK, AND US AND ITS ASSOCIATION WITH ANXIETY AND DEPRESSION, AND WORK PRODUCTIVITY: RESULTS FROM EPILUTS
KS Coyne, C Sexton, D Weinstein, I Milsom, CE Bitoun, Z Kopp, ...
European Urology Supplements 4 (8), 135, 2009
12009
The system can't perform the operation now. Try again later.
Articles 1–20